vs
CSW INDUSTRIALS, INC.（CSW）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是CSW INDUSTRIALS, INC.的1.3倍（$303.4M vs $233.0M），Sotera Health Co净利率更高（11.5% vs 4.4%，领先7.1%），CSW INDUSTRIALS, INC.同比增速更快（20.3% vs 4.6%），Sotera Health Co自由现金流更多（$52.4M vs $22.7M），过去两年Sotera Health Co的营收复合增速更高（10.6% vs 5.1%）
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
CSW vs SHC — 直观对比
营收规模更大
SHC
是对方的1.3倍
$233.0M
营收增速更快
CSW
高出15.8%
4.6%
净利率更高
SHC
高出7.1%
4.4%
自由现金流更多
SHC
多$29.7M
$22.7M
两年增速更快
SHC
近两年复合增速
5.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $233.0M | $303.4M |
| 净利润 | $10.3M | $34.8M |
| 毛利率 | 39.7% | 54.7% |
| 营业利润率 | 7.4% | 23.2% |
| 净利率 | 4.4% | 11.5% |
| 营收同比 | 20.3% | 4.6% |
| 净利润同比 | -61.9% | 182.8% |
| 每股收益（稀释后） | $0.62 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSWSHC
| Q4 25 | $233.0M | $303.4M | ||
| Q3 25 | $277.0M | $311.3M | ||
| Q2 25 | $263.6M | $294.3M | ||
| Q1 25 | $230.5M | $254.5M | ||
| Q4 24 | $193.6M | $290.2M | ||
| Q3 24 | $227.9M | $285.5M | ||
| Q2 24 | $226.2M | $276.6M | ||
| Q1 24 | $210.9M | $248.2M |
净利润CSWSHC
| Q4 25 | $10.3M | $34.8M | ||
| Q3 25 | $40.7M | $48.4M | ||
| Q2 25 | $40.9M | $8.0M | ||
| Q1 25 | $35.1M | $-13.3M | ||
| Q4 24 | $26.9M | $12.3M | ||
| Q3 24 | $36.1M | $17.0M | ||
| Q2 24 | $38.6M | $8.8M | ||
| Q1 24 | $31.8M | $6.3M |
毛利率CSWSHC
| Q4 25 | 39.7% | 54.7% | ||
| Q3 25 | 43.0% | 57.0% | ||
| Q2 25 | 43.8% | 56.6% | ||
| Q1 25 | 44.2% | 53.2% | ||
| Q4 24 | 41.4% | 56.6% | ||
| Q3 24 | 45.6% | 55.4% | ||
| Q2 24 | 47.5% | 55.2% | ||
| Q1 24 | 44.4% | 51.2% |
营业利润率CSWSHC
| Q4 25 | 7.4% | 23.2% | ||
| Q3 25 | 20.5% | 23.4% | ||
| Q2 25 | 20.8% | 6.4% | ||
| Q1 25 | 19.5% | -5.8% | ||
| Q4 24 | 15.3% | 30.0% | ||
| Q3 24 | 22.6% | 28.2% | ||
| Q2 24 | 24.3% | 27.8% | ||
| Q1 24 | 21.0% | 21.4% |
净利率CSWSHC
| Q4 25 | 4.4% | 11.5% | ||
| Q3 25 | 14.7% | 15.5% | ||
| Q2 25 | 15.5% | 2.7% | ||
| Q1 25 | 15.2% | -5.2% | ||
| Q4 24 | 13.9% | 4.2% | ||
| Q3 24 | 15.8% | 6.0% | ||
| Q2 24 | 17.1% | 3.2% | ||
| Q1 24 | 15.1% | 2.5% |
每股收益（稀释后）CSWSHC
| Q4 25 | $0.62 | $0.12 | ||
| Q3 25 | $2.41 | $0.17 | ||
| Q2 25 | $2.43 | $0.03 | ||
| Q1 25 | $2.05 | $-0.05 | ||
| Q4 24 | $1.60 | $0.05 | ||
| Q3 24 | $2.26 | $0.06 | ||
| Q2 24 | $2.47 | $0.03 | ||
| Q1 24 | $2.03 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | $344.6M |
| 总债务越低越好 | — | $2.1B |
| 股东权益账面价值 | $1.1B | $606.0M |
| 总资产 | $2.3B | $3.3B |
| 负债/权益比越低杠杆越低 | — | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资CSWSHC
| Q4 25 | $40.2M | $344.6M | ||
| Q3 25 | $31.5M | $299.2M | ||
| Q2 25 | $38.0M | $332.4M | ||
| Q1 25 | $225.8M | $304.4M | ||
| Q4 24 | $213.8M | $277.2M | ||
| Q3 24 | $273.2M | $306.7M | ||
| Q2 24 | $18.9M | $246.1M | ||
| Q1 24 | $22.2M | $261.1M |
总债务CSWSHC
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | $800.1M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | $166.0M | $2.2B |
股东权益CSWSHC
| Q4 25 | $1.1B | $606.0M | ||
| Q3 25 | $1.1B | $550.5M | ||
| Q2 25 | $1.1B | $511.3M | ||
| Q1 25 | $1.1B | $414.1M | ||
| Q4 24 | $1.0B | $404.9M | ||
| Q3 24 | $1.0B | $470.2M | ||
| Q2 24 | $650.2M | $422.8M | ||
| Q1 24 | $615.7M | $429.4M |
总资产CSWSHC
| Q4 25 | $2.3B | $3.3B | ||
| Q3 25 | $1.5B | $3.2B | ||
| Q2 25 | $1.5B | $3.2B | ||
| Q1 25 | $1.4B | $3.1B | ||
| Q4 24 | $1.4B | $3.1B | ||
| Q3 24 | $1.4B | $3.1B | ||
| Q2 24 | $1.1B | $3.1B | ||
| Q1 24 | $1.0B | $3.1B |
负债/权益比CSWSHC
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | 0.75× | 5.36× | ||
| Q4 24 | — | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | 0.27× | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $22.7M | $52.4M |
| 自由现金流率自由现金流/营收 | 9.8% | 17.3% |
| 资本支出强度资本支出/营收 | 2.6% | 16.7% |
| 现金转化率经营现金流/净利润 | 2.81× | 2.96× |
| 过去12个月自由现金流最近4个季度 | $162.0M | $149.2M |
8季度趋势，按日历期对齐
经营现金流CSWSHC
| Q4 25 | $28.9M | $103.1M | ||
| Q3 25 | $61.8M | $71.2M | ||
| Q2 25 | $60.6M | $57.4M | ||
| Q1 25 | $27.3M | $55.5M | ||
| Q4 24 | $11.6M | $55.7M | ||
| Q3 24 | $66.8M | $97.5M | ||
| Q2 24 | $62.7M | $61.3M | ||
| Q1 24 | $22.4M | $9.7M |
自由现金流CSWSHC
| Q4 25 | $22.7M | $52.4M | ||
| Q3 25 | $58.7M | $35.0M | ||
| Q2 25 | $57.7M | $26.2M | ||
| Q1 25 | $22.8M | $35.6M | ||
| Q4 24 | $8.5M | $-10.2M | ||
| Q3 24 | $61.3M | $61.1M | ||
| Q2 24 | $59.6M | $19.4M | ||
| Q1 24 | $17.5M | $-25.2M |
自由现金流率CSWSHC
| Q4 25 | 9.8% | 17.3% | ||
| Q3 25 | 21.2% | 11.2% | ||
| Q2 25 | 21.9% | 8.9% | ||
| Q1 25 | 9.9% | 14.0% | ||
| Q4 24 | 4.4% | -3.5% | ||
| Q3 24 | 26.9% | 21.4% | ||
| Q2 24 | 26.3% | 7.0% | ||
| Q1 24 | 8.3% | -10.2% |
资本支出强度CSWSHC
| Q4 25 | 2.6% | 16.7% | ||
| Q3 25 | 1.1% | 11.6% | ||
| Q2 25 | 1.1% | 10.6% | ||
| Q1 25 | 2.0% | 7.8% | ||
| Q4 24 | 1.6% | 22.7% | ||
| Q3 24 | 2.4% | 12.7% | ||
| Q2 24 | 1.4% | 15.2% | ||
| Q1 24 | 2.3% | 14.1% |
现金转化率CSWSHC
| Q4 25 | 2.81× | 2.96× | ||
| Q3 25 | 1.52× | 1.47× | ||
| Q2 25 | 1.48× | 7.21× | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | 4.52× | ||
| Q3 24 | 1.85× | 5.73× | ||
| Q2 24 | 1.62× | 7.00× | ||
| Q1 24 | 0.71× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
